April 21, 2018 5:50 AM ET

Biotechnology

Company Overview of Noveome Biotherapeutics, Inc.

Key Executives for Noveome Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
A. Clarke Atwell MIBS5 RelationshipsChief Executive Officer, President and Director--
William J. Golden CFA9 RelationshipsCo-Founder, Chairman, Chief Financial Officer and Executive Vice President--
Kenneth J. Mandell M.D., Ph.D.No RelationshipsChief Medical Officer--
Randall G. Rupp Ph.D.No RelationshipsExecutive Vice President of Manufacturing and Development69

Noveome Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
William J. Golden CFA 9 RelationshipsNoveome Biotherapeutics, Inc.--
A. Clarke Atwell MIBS 5 RelationshipsNoveome Biotherapeutics, Inc.--
John Hector McArthur 66 RelationshipsKoç Holding Anonim Sirketi82
Donald J. Wagner Sr. 5 RelationshipsNoveome Biotherapeutics, Inc.--
Terence C. Golden 28 RelationshipsFederal City Council72
View All Board Members

Noveome Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
385.8K
Bonus
248.9K
Total Short Term Compensation
382.8K
Total Value of Options
4.6M
Compensation as of Fiscal Year
Noveome Biotherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

NantKwest, Inc. Announces Resignation of John T. Potts from Board of Directors
April 17, 2018 8:45 PM ET
Kathryn J. Collier Joins Regulus Therapeutics Inc.'s Board of Directors
April 17, 2018 8:10 PM ET
Five Prime Therapeutics, Inc Appoints Linda Rubinstein as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
April 17, 2018 8:06 PM ET
Andres Gutierrez to Resign as a Chief Medical Officer of Oncolytics Biotech Inc., Effective April 23, 2018
April 17, 2018 8:00 PM ET
Bavarian Nordic A/S Announces Resignation of Claus Bræstrup as Director
April 17, 2018 3:51 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Noveome Biotherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.